menu
    • menu

    Company profile for Medivir

    NEW Drugs in Dev: 7
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medivir is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer. To do this efficiently and with a high success rate, we bring together a unique combination of clinical development skills, a collaborative culture and an extensive industry experience, with a balanced project portfolio. Medivir is listed on Nasdaq Stockholm's Small Cap list

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedivirSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Box 1086 SE-141 22 Huddinge
    Telephone
    Telephone
    +46 (0)8 5468 31 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medivir.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medivir Announces First Patient Enrolled In FLEX-HCC Study
    Medivir Announces First Patient Enrolled In FLEX-HCC Study

    21 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-21/medivir-announces-first-patient-enrolled-in-flex-hcc-study

    PHARMIWEB
    21 May 2026
    Share Share
    Medivir Joins Nordic Health Summit and BIO KOREA 2026
    Medivir Joins Nordic Health Summit and BIO KOREA 2026

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/medivir-participates-in-the-partner-and-investor-conferences-nordic-health-summit-in-japankorea-and-bio-korea-2026

    PHARMIWEB
    21 Apr 2026
    Share Share
    Medivir Presenting At The Redeye Fight Cancer Event 2026
    Medivir Presenting At The Redeye Fight Cancer Event 2026

    20 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-20/medivir-presenting-at-the-redeye-fight-cancer-event-2026

    PHARMIWEB
    20 Jan 2026
    Share Share
    FDA Grants Medivir Orphan Drug Designation For MIV-711
    FDA Grants Medivir Orphan Drug Designation For MIV-711

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/fda-grants-medivir-s-miv-711-orphan-drug-designation-for-the-treatment-of-osteogenesis-imperfecta

    PHARMIWEB
    27 Nov 2025
    Share Share
    Medivir Presenting At The Aktiespararnas Stora Aktiedagar
    Medivir Presenting At The Aktiespararnas Stora Aktiedagar

    26 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-26/medivir-presenting-at-the-aktiespararnas-stora-aktiedagar

    PHARMIWEB
    26 Nov 2025
    Share Share
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal
    Medivir Licenses Remetinostat To Biossil In Exclusive Deal

    23 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-23/medivir-enters-exclusive-licensing-agreement-with-biossil-inc-for-remetinostat

    PHARMIWEB
    23 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search